• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用I类主要组织相容性复合体限制抗体进行T细胞重定向:CD28共刺激结构域增强抗原特异性细胞毒性和细胞因子产生。

T cell retargeting with MHC class I-restricted antibodies: the CD28 costimulatory domain enhances antigen-specific cytotoxicity and cytokine production.

作者信息

Willemsen Ralph A, Ronteltap Cees, Chames Patrick, Debets Reno, Bolhuis Reinder L H

机构信息

Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus Medisch Centrum Daniel den hoed, Rotterdam, The Netherlands.

出版信息

J Immunol. 2005 Jun 15;174(12):7853-8. doi: 10.4049/jimmunol.174.12.7853.

DOI:10.4049/jimmunol.174.12.7853
PMID:15944290
Abstract

T cells require both primary and costimulatory signals for optimal activation. The primary Ag-specific signal is delivered by engagement of the TCR. The second Ag-independent costimulatory signal is mediated by engagement of the T cell surface costimulatory molecule CD28 with its target cell ligand B7. However, many tumor cells do not express these costimulatory molecules. We previously constructed phage display derived F(AB), G8, and Hyb3, Ab-based receptors with identical specificity but distinct affinities for HLA-A1/MAGE-A1, i.e., "TCR-like" specificity. These chimeric receptors comprised the FcepsilonRI-gamma signaling element. We analyzed whether linking the CD28 costimulation structure to it (gamma + CD28) could affect the levels of MHC-restricted cytolysis and/or cytokine production. Human scFv-G8(POS) T lymphocytes comprising the gamma + CD28 vs the gamma signaling element alone produced substantially more IL-2, TNF-alpha, and IFN-gamma in response to HLA-A1/MAGE-A1(POS) melanoma cells. Also a drastic increase in cytolytic capacity of scFv-G8(POS) T cells, equipped with gamma + CD28 vs the gamma-chain alone was observed.

摘要

T细胞需要初级信号和共刺激信号才能实现最佳激活。初级抗原特异性信号通过TCR的结合来传递。第二个非抗原性共刺激信号是由T细胞表面共刺激分子CD28与其靶细胞配体B7的结合介导的。然而,许多肿瘤细胞不表达这些共刺激分子。我们之前构建了基于噬菌体展示的F(AB)、G8和Hyb3,这些基于抗体的受体对HLA-A1/MAGE-A1具有相同的特异性但亲和力不同,即“TCR样”特异性。这些嵌合受体包含FcepsilonRI-γ信号元件。我们分析了将CD28共刺激结构与之连接(γ + CD28)是否会影响MHC限制性细胞溶解水平和/或细胞因子产生。与仅包含γ信号元件的人scFv-G8(POS) T淋巴细胞相比,包含γ + CD28的T淋巴细胞在对HLA-A1/MAGE-A1(POS)黑色素瘤细胞的反应中产生了更多的IL-2、TNF-α和IFN-γ。同样,观察到配备γ + CD28的scFv-G8(POS) T细胞与仅含γ链的细胞相比,其细胞溶解能力急剧增加。

相似文献

1
T cell retargeting with MHC class I-restricted antibodies: the CD28 costimulatory domain enhances antigen-specific cytotoxicity and cytokine production.使用I类主要组织相容性复合体限制抗体进行T细胞重定向:CD28共刺激结构域增强抗原特异性细胞毒性和细胞因子产生。
J Immunol. 2005 Jun 15;174(12):7853-8. doi: 10.4049/jimmunol.174.12.7853.
2
TCR-like human antibodies expressed on human CTLs mediate antibody affinity-dependent cytolytic activity.在人类细胞毒性T淋巴细胞(CTLs)上表达的TCR样人类抗体介导抗体亲和力依赖性细胞溶解活性。
J Immunol. 2002 Jul 15;169(2):1110-8. doi: 10.4049/jimmunol.169.2.1110.
3
Rejection of syngeneic colon carcinoma by CTLs expressing single-chain antibody receptors codelivering CD28 costimulation.表达共同递送CD28共刺激的单链抗体受体的细胞毒性T淋巴细胞对同基因结肠癌的排斥反应
J Immunol. 2002 Nov 15;169(10):5780-6. doi: 10.4049/jimmunol.169.10.5780.
4
Activation of resting human primary T cells with chimeric receptors: costimulation from CD28, inducible costimulator, CD134, and CD137 in series with signals from the TCR zeta chain.用嵌合受体激活静息人类原代T细胞:来自CD28、诱导性共刺激分子、CD134和CD137的共刺激与来自TCR ζ链的信号串联。
J Immunol. 2004 Jan 1;172(1):104-13. doi: 10.4049/jimmunol.172.1.104.
5
Redirecting mouse CTL against colon carcinoma: superior signaling efficacy of single-chain variable domain chimeras containing TCR-zeta vs Fc epsilon RI-gamma.将小鼠细胞毒性T淋巴细胞重定向用于对抗结肠癌:含TCR-zeta与FcεRI-γ的单链可变域嵌合体具有更高的信号传导效率
J Immunol. 2001 Jan 1;166(1):182-7. doi: 10.4049/jimmunol.166.1.182.
6
Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule.重组免疫受体介导的肿瘤特异性T细胞激活:高效分泌白细胞介素-2同时需要CD3 ζ信号传导和CD28共刺激,并且可将它们整合到一个联合的CD28/CD3 ζ信号受体分子中。
J Immunol. 2001 Dec 1;167(11):6123-31. doi: 10.4049/jimmunol.167.11.6123.
7
A phage display selected fab fragment with MHC class I-restricted specificity for MAGE-A1 allows for retargeting of primary human T lymphocytes.一种通过噬菌体展示筛选出的、对MAGE-A1具有MHC I类限制性特异性的Fab片段,可用于重定向原代人T淋巴细胞。
Gene Ther. 2001 Nov;8(21):1601-8. doi: 10.1038/sj.gt.3301570.
8
Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.通过CD8(+) T细胞释放粒细胞巨噬细胞集落刺激因子而非细胞溶解作用来检测自然加工且由HLA - A1呈递的黑色素瘤T细胞表位。
Clin Cancer Res. 1996 Jan;2(1):87-95.
9
Specific lysis of melanoma cells by receptor grafted T cells is enhanced by anti-idiotypic monoclonal antibodies directed to the scFv domain of the receptor.针对受体scFv结构域的抗独特型单克隆抗体可增强受体嫁接T细胞对黑色素瘤细胞的特异性裂解作用。
J Invest Dermatol. 1999 May;112(5):744-50. doi: 10.1046/j.1523-1747.1999.00586.x.
10
Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library.从非免疫噬菌体Fab文库中直接筛选针对肿瘤T细胞表位HLA-A1-MAGE-A1的人抗体片段。
Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):7969-74. doi: 10.1073/pnas.97.14.7969.

引用本文的文献

1
A SARS-CoV-2-specific CAR-T-cell model identifies felodipine, fasudil, imatinib, and caspofungin as potential treatments for lethal COVID-19.一种针对 SARS-CoV-2 的嵌合抗原受体 T 细胞模型鉴定出非洛地平、法舒地尔、伊马替尼和卡泊芬净可能是治疗致命性 COVID-19 的药物。
Cell Mol Immunol. 2023 Apr;20(4):351-364. doi: 10.1038/s41423-023-00985-3. Epub 2023 Mar 2.
2
Potent, Selective CARs as Potential T-Cell Therapeutics for HPV-positive Cancers.强效、选择性的嵌合抗原受体作为 HPV 阳性癌症的潜在 T 细胞治疗方法。
J Immunother. 2021 Oct 1;44(8):292-306. doi: 10.1097/CJI.0000000000000386.
3
T Cells Expressing a TCR-Like Antibody Selected Against the Heteroclitic Variant of a Shared MAGE-A Epitope Do Not Recognise the Cognate Epitope.
表达针对共享MAGE-A表位的异源性变体筛选出的类似TCR抗体的T细胞不识别同源表位。
Cancers (Basel). 2020 May 16;12(5):1255. doi: 10.3390/cancers12051255.
4
TCR-Like CAR-T Cells Targeting MHC-Bound Minor Histocompatibility Antigens.T 细胞受体样嵌合抗原受体 T 细胞靶向 MHC 结合的次要组织相容性抗原。
Front Immunol. 2020 Feb 28;11:257. doi: 10.3389/fimmu.2020.00257. eCollection 2020.
5
Targeting the MHC Ligandome by Use of TCR-Like Antibodies.利用类TCR抗体靶向主要组织相容性复合体配体组
Antibodies (Basel). 2019 May 9;8(2):32. doi: 10.3390/antib8020032.
6
Switching on the green light for chimeric antigen receptor T-cell therapy.为嵌合抗原受体T细胞疗法亮起绿灯。
Clin Transl Immunology. 2019 May 5;8(5):e1046. doi: 10.1002/cti2.1046. eCollection 2019.
7
Liposomes targeted to MHC-restricted antigen improve drug delivery and antimelanoma response.靶向 MHC 限制性抗原的脂质体可改善药物传递和抗黑色素瘤反应。
Int J Nanomedicine. 2019 Mar 26;14:2069-2089. doi: 10.2147/IJN.S190736. eCollection 2019.
8
The intersection of affinity and specificity in the development and optimization of T cell receptor based therapeutics.T 细胞受体为基础的治疗药物的开发和优化中的亲和力和特异性的交集。
Semin Cell Dev Biol. 2018 Dec;84:30-41. doi: 10.1016/j.semcdb.2017.10.017.
9
Synthetic immunology: T-cell engineering and adoptive immunotherapy.合成免疫学:T细胞工程与过继性免疫治疗
Synth Syst Biotechnol. 2018 Sep 1;3(3):179-185. doi: 10.1016/j.synbio.2018.08.001. eCollection 2018 Sep.
10
Strategies for Bispecific Single Chain Antibody in Cancer Immunotherapy.双特异性单链抗体在癌症免疫治疗中的策略
J Cancer. 2017 Oct 17;8(18):3689-3696. doi: 10.7150/jca.19501. eCollection 2017.